ANBT
XENE icon

American National Bank & Trust’s Xenon Pharmaceuticals XENE Stock Holding History

American National Bank & Trust’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5
Closed -$201 – 774
2025
Q3 		$201 Hold
5
– – ﹤0.01% 632
2025
Q2 		$157 Buy
+5
New +$163 ﹤0.01% 641

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

American National Bank & Trust's XENE Position: Q4 2025 in Review

American National Bank & Trust sold out of Xenon Pharmaceuticals (XENE) in Q4 2025, closing a stake of 5 shares — an estimated $201 sold.

American National Bank & Trust first reported a position in XENE in Q2 2025 and held it in 2 quarters. The position peaked at $201 in Q3 2025. 246 funds tracked by Wall St. Rank hold XENE as of Q4 2025.

  • American National Bank & Trust reported no remaining Xenon Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • American National Bank & Trust sold 5 Xenon Pharmaceuticals shares in Q4 2025, an estimated $201.
  • American National Bank & Trust first reported a position in Xenon Pharmaceuticals in Q2 2025 and held it in 2 quarters.
  • American National Bank & Trust's Xenon Pharmaceuticals position peaked at $201 in Q3 2025.
  • 246 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q4 2025.

Based on American National Bank & Trust's 13F filing for Q4 2025, filed 20 Jan 2026.